Fibromyalgia May Soon Be Reliably Diagnosed By Blood Test
In the absence of a blood test, clinicians rely on patient-reported symptoms and a physical evaluation of pain to diagnose fibromyalgia. Researchers from Ohio State University have identified a “metabolic fingerprint” of the disease that increases the probability a reliable blood test may be designed.
The investigators analyzed blood samples from 121 participants with similar disorders – 50 with fibromyalgia, 29 with rheumatoid arthritis, 23 with lupus, and 19 with osteoarthritis – to establish a baseline pattern for each diagnosis. Using 2 types of spectroscopy, the researchers evaluated the samples blindly and were able to accurately place each participant into the correct disease category based on a molecular signature. The scientists identified patterns that differentiated blood samples from participants with fibromyalgia from the others.
“We found clear, reproducible metabolic patterns in the blood of dozens of patients with fibromyalgia,” said lead researcher Kevin Hackshaw, an associate professor at Ohio State University’s College of Medicine. “This brings us much closer to a blood test than we have ever been.”
Although as of now the disease is incurable, Hackshaw believes an accurate diagnosis may yield many benefits. Namely, it can help clinicians rule out other diseases, confirm that patients’ symptoms aren’t imagined, and guide clinicians toward disease recognition and appropriate treatment.
Fibromyalgia is a complex condition that can cause widespread pain, fatigue, sleep problems, and difficulty concentrating. For many years, there has been no single laboratory test that can reliably confirm fibromyalgia. Diagnosis has generally depended on symptoms, medical history, and a physical examination.
However, researchers are studying whether specific changes in the blood could help identify fibromyalgia. Scientists are investigating biological markers, including patterns involving immune-system activity, metabolism, proteins, and other molecules found in blood samples.
A reliable blood test could be an important development for people living with fibromyalgia. It might help doctors identify the condition more objectively and potentially reduce the time some patients spend undergoing tests for other conditions that can cause similar symptoms.
Research in this area is promising, but it is important to understand that a blood test for fibromyalgia is not yet a universally accepted routine diagnostic test. Researchers still need to confirm that these tests work accurately across large and diverse groups of patients.
If future studies establish a dependable blood-based biomarker, diagnosis could become faster and easier. It could also improve awareness of fibromyalgia as a genuine medical condition that can significantly affect daily life.
Until such a test becomes clinically validated and widely available, anyone experiencing persistent widespread pain, fatigue, sleep difficulties, or other concerning symptoms should speak with a qualified healthcare professional.
The future of fibromyalgia diagnosis may be closer than ever—but more research is still needed before a blood test can reliably diagnose the condition.
